DINGDANG HEALTH TECHNOLOGY GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.04 HKD | 0.00% |
|
-7.96% | -47.74% |
| Apr. 01 | Dingdang Health Technology Slashes Losses in 2023 | MT |
| Mar. 28 | Dingdang Health Technology Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 4.86B 671M 5.26B | Sales 2024 * | 5.43B 750M 5.87B | Capitalization | 1.29B 178M 1.4B |
|---|---|---|---|---|---|
| Net income 2023 | -226M -31.23M -245M | Net income 2024 * | -92M -12.71M -99.55M | EV / Sales 2023 | 0.5 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 0.24 x |
| P/E ratio 2023 |
-10.6
x | P/E ratio 2024 * |
-13.7
x | Employees | 2,615 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 51.16% |
More Fundamentals
* Assessed data
More news
| 1 week | -7.96% | ||
| Current month | -9.57% | ||
| 1 month | -17.46% | ||
| 3 months | -39.88% | ||
| 6 months | -50.48% | ||
| Current year | -47.74% |
1 week
1.00
1.15
1 month
1.001.26
Current year
1.002.08
1 year
1.003.44
3 years
1.0020.20
5 years
1.0020.20
10 years
1.0020.20
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Long Yang
FOU | Founder | 62 | 14-08-19 |
Yiu Por Lam
DFI | Director of Finance/CFO | 47 | 21-01-14 |
Qing Long Yu
CTO | Chief Tech/Sci/R&D Officer | 39 | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wen Long Yang
FOU | Founder | 62 | 14-08-19 |
Li Cai
BRD | Director/Board Member | 40 | 21-05-25 |
Yi Bin Yang
BRD | Director/Board Member | 36 | 23-08-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 1.04 | 0.00% | 377,500 |
| 24-04-17 | 1.04 | +1.96% | 890,500 |
| 24-04-16 | 1.02 | -4.67% | 1,263,500 |
| 24-04-15 | 1.07 | +0.94% | 843,000 |
| 24-04-12 | 1.06 | -5.36% | 1,065,500 |
Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT
More quotes
Dingdang Health Technology Group Ltd is a China based company mainly engaged in the business of pharmaceutical retail and medical consultation. The Company operates two segments. Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. Others segment provides marketing services, marketplace services and other services. The Company mainly conducts businesses within the domestic market.
Sector
Drug Retailers
Calendar
2024-09-19
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9613
CNY
Average target price
1.366
CNY
Spread / Average Target
+42.10%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.74% | 178M | |
| -32.63% | 15.21B | |
| -40.54% | 9.41B | |
| -8.71% | 6.23B | |
| +8.02% | 5.91B | |
| -37.50% | 5.42B | |
| +2.34% | 4.89B | |
| +49.84% | 4.27B | |
| -13.27% | 3.51B | |
| -10.44% | 3.43B |
- Stock Market
- Equities
- 9886 Stock
